In conclusion, the differential expression, transcriptional profile, involvement in the cancer pathways alterations, and the interaction with cancer stem cells provide a new idea for targeted molecular therapy of MYC in breast cancer patients and provide clues and directions for a better understanding of the molecular mechanism of breast cancer tumorigenesis. The gene discussed is MYC; the disease is breast cancer.